Pilot study of Ixazomib, Lenalidomide, and Dexamethasone for Patients with POEMS Syndrome

POEMS syndrome is a rare paraneoplastic syndrome caused by an underlying plasma cell disorder. The combination of a proteasome inhibitor, an IMiD and corticosteroid is known to be highly effective among patients with myeloma.

Source: Clinical Lymphoma, Myeloma and Leukemia - September 30, 2019 Category: Hematology Authors: Angela Dispenzieri, Martha Lacy, Michelle Mauermann, Betsy LaPlant, Ronald Go, Prashant Kapoor, Yi Lisa Hwa, Amie Fonder, Miriam Hobbs, Francis Buadi, Suzanne Hayman, Nelson Leung, John Lust, David Dingli, Wilson Gonsalves, Taxiarchis Kourelis, Rahma Wars Source Type: research